PortfoliosLab logoPortfoliosLab logo
BOUT vs. BAPR
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

BOUT vs. BAPR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator U.S. Equity Buffer ETF - April (BAPR). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BOUT vs. BAPR - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
BOUT
Innovator IBD Breakout Opportunities ETF
8.23%-6.77%18.82%13.27%-22.60%22.69%50.56%3.05%
BAPR
Innovator U.S. Equity Buffer ETF - April
2.08%8.28%15.95%23.16%-7.04%12.58%6.19%10.49%

Returns By Period

In the year-to-date period, BOUT achieves a 8.23% return, which is significantly higher than BAPR's 2.08% return.


BOUT

1D
2.67%
1M
-3.79%
YTD
8.23%
6M
1.15%
1Y
8.69%
3Y*
8.84%
5Y*
4.03%
10Y*

BAPR

1D
2.58%
1M
0.99%
YTD
2.08%
6M
4.42%
1Y
15.33%
3Y*
13.43%
5Y*
10.13%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BOUT vs. BAPR - Expense Ratio Comparison

BOUT has a 0.80% expense ratio, which is higher than BAPR's 0.79% expense ratio.


Return for Risk

BOUT vs. BAPR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOUT
BOUT Risk / Return Rank: 2525
Overall Rank
BOUT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
BOUT Sortino Ratio Rank: 2424
Sortino Ratio Rank
BOUT Omega Ratio Rank: 2424
Omega Ratio Rank
BOUT Calmar Ratio Rank: 2828
Calmar Ratio Rank
BOUT Martin Ratio Rank: 2525
Martin Ratio Rank

BAPR
BAPR Risk / Return Rank: 8181
Overall Rank
BAPR Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
BAPR Sortino Ratio Rank: 7979
Sortino Ratio Rank
BAPR Omega Ratio Rank: 9292
Omega Ratio Rank
BAPR Calmar Ratio Rank: 6969
Calmar Ratio Rank
BAPR Martin Ratio Rank: 9090
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BOUT vs. BAPR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator U.S. Equity Buffer ETF - April (BAPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BOUTBAPRDifference

Sharpe ratio

Return per unit of total volatility

0.40

1.29

-0.89

Sortino ratio

Return per unit of downside risk

0.66

1.99

-1.33

Omega ratio

Gain probability vs. loss probability

1.09

1.40

-0.31

Calmar ratio

Return relative to maximum drawdown

0.65

1.74

-1.08

Martin ratio

Return relative to average drawdown

1.81

11.59

-9.77

BOUT vs. BAPR - Sharpe Ratio Comparison

The current BOUT Sharpe Ratio is 0.40, which is lower than the BAPR Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of BOUT and BAPR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


BOUTBAPRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.40

1.29

-0.89

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.21

0.88

-0.67

Sharpe Ratio (All Time)

Calculated using the full available price history

0.30

0.75

-0.45

Correlation

The correlation between BOUT and BAPR is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

BOUT vs. BAPR - Dividend Comparison

BOUT's dividend yield for the trailing twelve months is around 0.32%, while BAPR has not paid dividends to shareholders.


TTM20252024202320222021202020192018
BOUT
Innovator IBD Breakout Opportunities ETF
0.32%0.34%0.60%1.32%1.35%0.00%0.00%0.00%0.22%
BAPR
Innovator U.S. Equity Buffer ETF - April
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BOUT vs. BAPR - Drawdown Comparison

The maximum BOUT drawdown since its inception was -36.75%, which is greater than BAPR's maximum drawdown of -23.91%. Use the drawdown chart below to compare losses from any high point for BOUT and BAPR.


Loading graphics...

Drawdown Indicators


BOUTBAPRDifference

Max Drawdown

Largest peak-to-trough decline

-36.75%

-23.91%

-12.84%

Max Drawdown (1Y)

Largest decline over 1 year

-13.73%

-9.19%

-4.54%

Max Drawdown (5Y)

Largest decline over 5 years

-28.28%

-15.58%

-12.70%

Current Drawdown

Current decline from peak

-6.50%

0.00%

-6.50%

Average Drawdown

Average peak-to-trough decline

-12.55%

-2.66%

-9.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.95%

1.38%

+3.57%

Volatility

BOUT vs. BAPR - Volatility Comparison

Innovator IBD Breakout Opportunities ETF (BOUT) has a higher volatility of 8.61% compared to Innovator U.S. Equity Buffer ETF - April (BAPR) at 3.45%. This indicates that BOUT's price experiences larger fluctuations and is considered to be riskier than BAPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


BOUTBAPRDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.61%

3.45%

+5.16%

Volatility (6M)

Calculated over the trailing 6-month period

17.18%

4.26%

+12.92%

Volatility (1Y)

Calculated over the trailing 1-year period

21.74%

11.90%

+9.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.54%

11.54%

+8.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.96%

13.25%

+9.71%